420
Views
56
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood

, , , , , , & show all
Pages 129-137 | Received 11 May 2006, Published online: 08 Jul 2009

References

  • Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19: 679–88
  • Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515–8
  • Karzai W, Oberhoffer M, Meier-Hellman A, Reinhart K. Procalcitonin: a new indicator of the systemic response to severe infections. Infection 1997; 6: 329–34
  • Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240–2
  • Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C-reactive protein and leukocyte count. Arch Dis Child 1999; 81: 417–21
  • Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J, et al. Procalcitonin as a marker for the early diagnosis of neonatal bacterial infection. J Pediatr 1996; 128: 570–3
  • Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guerin S, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J 1999; 18: 875–81
  • Chiesa C, Panero A, Rossi NA, Stegagno M, de Giusti M, Osborn JF, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998; 26: 664–72
  • Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250–6
  • Suprin E, Camus C, Gacouin A, Le Tulzo Y, Lavoue S, Feuillu A, et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000; 26: 1170–1
  • Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206–17
  • British Thoracic Society Standards of Care Committee. British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax 2002;57((Suppl 1)):1–24.
  • McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002; 346: 429–37
  • Heiskanen-Kosma T, Korppi M, Leinonen M. Serologically indicated pneumococcal pneumonia in children: a population-based study in primary care settings. APMIS 2003; 111: 945–50
  • Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, et al. Aetiology of childhood pneumonia: serological results of a prospective, population-based study. Pediatr Infect Dis J 1998; 17: 986–91
  • Korppi M, Leinonen M. Pneumococcal immune complexes in the diagnosis of lower respiratory infections in children. Pediatr Infect Dis J 1998; 17: 992–5
  • Nohynek H, Valkeila E, Leinonen M, Eskola J. Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing aetiological diagnosis of acute lower respiratory infections in children. Pediatr Infect Dis J 1995; 14: 484–90
  • Korppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997; 10: 1125–9
  • Heiskanen-Kosma T, Korppi M. Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings. Scand J Infect Dis 2000; 32: 399–402
  • Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 2001; 17: 623–7
  • Korppi M, Remes S, Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings. Pediatr Pulmonol 2003; 35: 56–61
  • Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19: 596–602
  • Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez J-L, et al. Procalcitonin in children admitted to hospital with community-acquired pneumonia. Arch Dis Child 2001; 84: 332–6
  • Pratt C, Dominguez J, Rodrigo C, Gimenez M, Azuara M, Jimenez O, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J 2003; 22: 963–7
  • Don M, Fasoli L, Paldanius M, Vainionpää R, Kleemola M, Räty R, et al. Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand J Infect Dis 2005; 37: 806–12
  • Nohynek H, Eskola J, Kleemola M, Jalonen E, Saikku P, Leinonen M. Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr Infect Dis J 1995; 14: 478–84
  • Kenny GE, Grayston JT. Eaton pleuropneumonia-like organism (Mycoplasma pneumoniae) complement-fixing antigen: extraction with organic solvents. J Immunol 1965; 95: 19–25
  • Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004; 9: 109–14
  • Persson K, Boman J. Comparison of 5 serological tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol 2000; 7: 739–44
  • Wang S. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation. J Infect Dis 2000; 181(Suppl 3)S421–5
  • Vuorinen T, Meurman O. Enzyme immunoassays for detection of IgG and IgM antibodies to parainfluenza types 1, 2 and 3. Journal of Virological Methods 1989; 23: 63–70
  • Ziegler T, Lindholm T, Scalia G. Causes of false-positive reactions in herpes virus IgM assays. Serodiagnosis and Immunotherapy in Infectious Diseases 1989; 3: 101–9
  • Laine M, Vainionpää R, Uksila J, Oksi J, Nissilä M, Kaarela K, et al. Prevalence of Sindbis-related (Pogosta) virus infections in patients with arthritis. Clin Exp Rheumatol 2003; 21: 213–6
  • Madhi, SA, Klugman, KP, and The Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004;10:811–3.
  • Korppi M. Mixed microbial aetiology of community-acquired pneumonia in children. APMIS 2002; 110: 515–22
  • Mistchenko AS, Diez R, Mariani AL, Robaldo J, Maffey AF, Bayley-Bustamante G, et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumour necrosis factor alpha levels with clinical outcome. J Pediatr 1994; 124: 714–20
  • Vuori, E, Peltola, H, Kallio, MJY, Leinonen, M, Heidman, K, SE-TU Study Group. Aetiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. Clin Infect Dis 1998;27:566–72.
  • Haterill M, Sykes K, McIntyre AG, Murdoch IA. Procalcitonin may help differentiate disseminated herpes simplex viral from bacterial sepsis in neonates. Eur J Pediatr 2000; 159: 168–9
  • Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005; 33: 257–63
  • Jennings LC, Anderson TP, Werno AM, Beynon KA, Murdoch DR. Viral aetiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections. Pediatr Infect Dis J 2004; 23: 1003–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.